![Standard-dose and high-dose daily antiviral therapy for short episodes of genital HSV-2 reactivation: three randomised, open-label, cross-over trials - The Lancet Standard-dose and high-dose daily antiviral therapy for short episodes of genital HSV-2 reactivation: three randomised, open-label, cross-over trials - The Lancet](https://www.thelancet.com/cms/attachment/a6e04134-5021-4c69-8936-add20f5e935d/gr1.gif)
Standard-dose and high-dose daily antiviral therapy for short episodes of genital HSV-2 reactivation: three randomised, open-label, cross-over trials - The Lancet
![Daily aciclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial - The Lancet Daily aciclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial - The Lancet](https://www.thelancet.com/cms/attachment/2001010456/2003789883/gr1.gif)
Daily aciclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial - The Lancet
![NCCN Prevention and Treatment of Cancer-Related Infections Guidelines Update (Slides with Transcript) NCCN Prevention and Treatment of Cancer-Related Infections Guidelines Update (Slides with Transcript)](https://img.medscapestatic.com/slide/migrated/editorial/cmecircle/2007/7017/images/46.jpg)
NCCN Prevention and Treatment of Cancer-Related Infections Guidelines Update (Slides with Transcript)
![Frontiers | Omeprazole Increases the Efficacy of Acyclovir Against Herpes Simplex Virus Type 1 and 2 Frontiers | Omeprazole Increases the Efficacy of Acyclovir Against Herpes Simplex Virus Type 1 and 2](https://www.frontiersin.org/files/Articles/485564/fmicb-10-02790-HTML/image_m/fmicb-10-02790-g001.jpg)
Frontiers | Omeprazole Increases the Efficacy of Acyclovir Against Herpes Simplex Virus Type 1 and 2
Infectious ง่ายนิดเดียว - 📌ขนาดยา Acyclovir ในผู้ใหญ่และเด็ก📌 --------------------------------------- 🙊(1)HSV โรคเริม :แรกเกิดถึง3เดือน:IV:60mg/kg/day แบ่ง3เวลา (ถ้าEncephalitisให้21วัน/skin:eye:mouth-14วัน) :3เดือน-12ปี:30-45mg/kg/day แต่ FDA อาจ ...
![Antiviral prophylaxis for preventing herpes zoster in hematopoietic stem cell transplant recipients: A systematic review and meta‐analysis | Semantic Scholar Antiviral prophylaxis for preventing herpes zoster in hematopoietic stem cell transplant recipients: A systematic review and meta‐analysis | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/45dd12781a91c7ab2228a130bfdcacd8addeaaa0/4-Table1-1.png)
Antiviral prophylaxis for preventing herpes zoster in hematopoietic stem cell transplant recipients: A systematic review and meta‐analysis | Semantic Scholar
![Management of Acyclovir-Resistant Herpes Simplex Virus Infection in Patients Undergoing Hematopoietic Stem-Cell Transplantation Management of Acyclovir-Resistant Herpes Simplex Virus Infection in Patients Undergoing Hematopoietic Stem-Cell Transplantation](https://jhoponline.com/images/jhop/2021/August/Management_table.jpg)
Management of Acyclovir-Resistant Herpes Simplex Virus Infection in Patients Undergoing Hematopoietic Stem-Cell Transplantation
![Prophylactic role of long-term ultra-low-dose acyclovir for varicella zoster virus disease after allogeneic hematopoietic stem cell transplantation - ScienceDirect Prophylactic role of long-term ultra-low-dose acyclovir for varicella zoster virus disease after allogeneic hematopoietic stem cell transplantation - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1201971213003123-gr1.jpg)
Prophylactic role of long-term ultra-low-dose acyclovir for varicella zoster virus disease after allogeneic hematopoietic stem cell transplantation - ScienceDirect
![SciELO - Brasil - A non-randomized comparative study using different doses of acyclovir to prevent herpes simplex reactivation in patients submitted to autologous stem cell transplantation A non-randomized comparative study using different SciELO - Brasil - A non-randomized comparative study using different doses of acyclovir to prevent herpes simplex reactivation in patients submitted to autologous stem cell transplantation A non-randomized comparative study using different](https://minio.scielo.br/documentstore/1678-4391/sS9hv3MqpWFvpyCx343rTVb/385a59b30af9d67ffd46220940f11b55c1613c5d.gif)
SciELO - Brasil - A non-randomized comparative study using different doses of acyclovir to prevent herpes simplex reactivation in patients submitted to autologous stem cell transplantation A non-randomized comparative study using different
![Treatment of Acyclovir-Resistant Herpes Simplex Virus with Continuous Infusion of High-Dose Acyclovir in Hematopoietic Cell Transplant Patients - Biology of Blood and Marrow Transplantation Treatment of Acyclovir-Resistant Herpes Simplex Virus with Continuous Infusion of High-Dose Acyclovir in Hematopoietic Cell Transplant Patients - Biology of Blood and Marrow Transplantation](https://www.astctjournal.org/cms/attachment/7f29fa8d-699c-4830-be21-c7bf16805694/gr1_lrg.jpg)
Treatment of Acyclovir-Resistant Herpes Simplex Virus with Continuous Infusion of High-Dose Acyclovir in Hematopoietic Cell Transplant Patients - Biology of Blood and Marrow Transplantation
![Table 6 from The treatment of herpes simplex infections: an evidence-based review. | Semantic Scholar Table 6 from The treatment of herpes simplex infections: an evidence-based review. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/301f8b538b7a00695af50b7b9c0135497acddded/5-Table6-1.png)